Literature DB >> 5910014

Liver carcinogenesis by diethylnitrosamine in the rat.

M F Rajewsky, W Dauber, H Frankenberg.   

Abstract

Diethylnitrosamine was continuously administered to rats at a dose rate of low toxicity. Ninety-two percent of the animals died with multicentrical hepatocellular carcinomata within a narrow and highly reproducible time interval. Discontinuing the carcinogen during the experiment resulted in a prolonged median time until death, a reduced tumor yield, and a lessened slope of the dose-response curve. Partial hepatectomy after discontinuation of the drug did not change either tumor yield or time of death. The obtained dose-response relationships support the concept that carcinogenic effects of single doses are irreversible and cumulative. Daily, low-dose, total-body x-irradiation had no significant effect on the response of rat liver to the carcinogen.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5910014     DOI: 10.1126/science.152.3718.83

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  25 in total

1.  Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis.

Authors:  Wantae Kim; Sanjoy Kumar Khan; Jelena Gvozdenovic-Jeremic; Youngeun Kim; Jason Dahlman; Hanjun Kim; Ogyi Park; Tohru Ishitani; Eek-Hoon Jho; Bin Gao; Yingzi Yang
Journal:  J Clin Invest       Date:  2016-11-21       Impact factor: 14.808

2.  [Quantitative studies on the irreversible loss of two enzyme activities in the rat liver after application of diethylnitrosamine (author's transl)].

Authors:  G Schieferstein; J Pirschel; W Frank; H Friedrich-Freksa
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

3.  [Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats].

Authors:  H Druckrey; R Preussmann; S Ivankovic; D Schmähl
Journal:  Z Krebsforsch       Date:  1967

4.  [Histochemical investigations of carcinogenesis in rat liver after continuous application of diethylnitrosamine].

Authors:  H Friedrich-Freksa; W Gössner; P Börner
Journal:  Z Krebsforsch       Date:  1969

5.  [Histochemical investigations of carcinogenesis in rat liver after time-limited application of diethylnitrosamine].

Authors:  H Friedrich-Freksa; G Papadopulu; W Gössner
Journal:  Z Krebsforsch       Date:  1969

Review 6.  Mouse models for liver cancer.

Authors:  Latifa Bakiri; Erwin F Wagner
Journal:  Mol Oncol       Date:  2013-02-05       Impact factor: 6.603

7.  DNA damage-induced sustained p53 activation contributes to inflammation-associated hepatocarcinogenesis in rats.

Authors:  H-X Yan; H-P Wu; H-L Zhang; C Ashton; C Tong; J Wu; Q-J Qian; H-Y Wang; Q-L Ying
Journal:  Oncogene       Date:  2012-10-15       Impact factor: 9.867

8.  p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release.

Authors:  He-Xin Yan; Hong-Ping Wu; Hui-Lu Zhang; Charles Ashton; Chang Tong; Han Wu; Qi-Jun Qian; Hong-Yang Wang; Qi-Long Ying
Journal:  J Hepatol       Date:  2013-05-25       Impact factor: 25.083

9.  Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis.

Authors:  Bo Kong; Yan Zhu; Guodong Li; Jessica A Williams; Kyle Buckley; Ossama Tawfik; James P Luyendyk; Grace L Guo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-07       Impact factor: 4.052

10.  Thyroid hormone suppresses hepatocarcinogenesis via DAPK2 and SQSTM1-dependent selective autophagy.

Authors:  Hsiang-Cheng Chi; Shen-Liang Chen; Chung-Ying Tsai; Wen-Yu Chuang; Ya-Hui Huang; Ming-Ming Tsai; Sheng-Ming Wu; Cheng-Pu Sun; Chau-Ting Yeh; Kwang-Huei Lin
Journal:  Autophagy       Date:  2016-09-21       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.